© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
July 27, 2021
The proportion of eyes that developed PDR or centre-involving DMO was lower with periodic aflibercept treatments compared with sham treatment through the 2-year point.
July 26, 2021
Following a discussion regarding drug delivery challenges in retinal disease, a panel of global experts suggest what types of technological requirements and improvements they would like to see occur in the field.
July 26, 2021
Challenges associated with delivering therapies currently available to treat retinal disorders and methods being explored to improve drug delivery to patients.
July 19, 2021
Drawbacks and challenges associated with the administration of anti-VEGF injections currently available to treat retinal diseases.
July 19, 2021
Dr Mariya Moosajee highlights therapies approved as well as under study to improve treatment for patients with inherited retinal disease.
July 12, 2021
A discussion regarding the roles of various treatments available for diabetic macular edema and considerations for selecting and sequencing therapy.
July 12, 2021
An overview of the current treatment landscape for age-related macular degeneration and factors that impact treatment selection.
June 30, 2021
Types of tests and criteria that can be used to diagnose conditions such as age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
June 30, 2021
A panel of global experts who treat patients with retinal diseases suggest causes of age-related macular degeneration, diabetic macular edema, and inherited retinal disease.
June 30, 2021
According to researchers, fluorescence lifetime imaging ophthalmoscopy reveals disease-related patterns not visible with other imaging modalities.